Thrive Market, an online marketplace for healthy foods, has raised $111 million in a new round of financing led by Invus. Greycroft Partners, E-Ventures and Cross Culture Ventures, all previous investors in the company, also participated. Customers of Thrive pay $60 a year to buy organic food at lower prices than traditional grocers, according to the company.
Orbital Insight, a geospatial big data company, has raised $15 million in a Series B round led by GV. CME Ventures and existing backers Sequoia Capital, Lux Capital and Bloomberg Beta all participated in the round. Orbital has also secured another $5 million from an investment and development agreement with In-Q-Tel. “Orbital Insight’s first two years were spent building a product to change the way people see the world,” said Dr. James Crawford, founder and CEO of Orbital Insight. “Extending our investor partnerships to CME Ventures and In-Q-Tel, and reaffirming our relationship with GV and Sequoia Capital, Lux Capital, and Bloomberg Beta positions us well for the future.”
Singapore-based bitcoin exchange company Quoine has raised $16 million as part of an ongoing Series A financing round. The company is looking to raise another $4 million in the coming months to bring the round to $20 million. Investment fund JAFCO participated in the round, as did a group of undisclosed angel investors. Quoine is in the process of moving its headquarters to Japan.
AFFiRis AG, a developer of therapeutic peptide vaccines against chronic diseases, has raised EUR10 million from existing investors and FCPB Affi. Return backers included MIG Funds and the Strungmann family. The company’s clinical pipeline consists of three drug candidates fighting Parkinson’s Disease, MSA and Hypercholesterolemia. Further vaccine candidates for diabetes, allergies, asthma and Huntington’s Disease are in preclinical development. AFFiRiS has attracted approximately EUR130 million in funding to date, half of which comes from license income and government grants. The company is based in Vienna, Austria.